Breast cancer is the most commonly occurring cancer in women. There were over two-
million new cases in world in 2018. It is the second leading cause of death from cancer in …

Estrogen receptor β (ERβ) is closely related to breast cancer (BC) progression. Traditional
concepts regard ERβ as a tumor suppressor. As studies show the carcinogenic effect of …

Studies have shown that the presence of tumor infiltrating lymphocytes (TILs) in Triple
Negative Breast Cancer (TNBC) is associated with better prognosis. However, the molecular …

Triple-negative breast cancer (TNBC) lacks estrogen receptor (ER) α, but the expression of
estrogen receptors ERβ and G protein-coupled estrogen receptor 1 (GPER-1) is able to …

Background: The cisplatin resistance of non-small cell lung cancer (NSCLC) patients results
in low response rate and overall survival rate. Exosomes contribute to pathological …

Breast cancer, a malignant tumor originating from mammary epithelial tissue, is the most
common cancer among women worldwide. Challenges facing the diagnosis and treatment …

Simple Summary Young women treated for breast cancer may experience early
menopause, which can negatively impact quality of life. The usual treatment for early …

Breast cancer (BC) is the most common type of cancer in women at the global level and the
highest mortality rate has been observed with triple-negative breast cancer (TNBC) …

Triple Negative Breast Cancer (TNBC) has the worst prognosis among all breast cancers,
and survival in patients with recurrence is rarely beyond 12 months due to acquired …

Simple Summary The presence of estrogen receptor beta, the androgen receptor, and the
glucocorticoid receptor on triple-negative breast cancer cells has opened the possibility for …